nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketobemidone—PTGS1—kidney cancer	0.442	1	CbGaD
Ketobemidone—UGT1A9—Sorafenib—kidney cancer	0.0963	0.192	CbGbCtD
Ketobemidone—CYP3A4—Everolimus—kidney cancer	0.0455	0.0909	CbGbCtD
Ketobemidone—CYP2C8—Pazopanib—kidney cancer	0.0398	0.0795	CbGbCtD
Ketobemidone—CYP3A4—Temsirolimus—kidney cancer	0.0307	0.0614	CbGbCtD
Ketobemidone—CYP2B6—Sorafenib—kidney cancer	0.0305	0.0609	CbGbCtD
Ketobemidone—CYP2C9—Capecitabine—kidney cancer	0.0289	0.0578	CbGbCtD
Ketobemidone—CYP2C8—Erlotinib—kidney cancer	0.0284	0.0567	CbGbCtD
Ketobemidone—CYP2C8—Paclitaxel—kidney cancer	0.026	0.0519	CbGbCtD
Ketobemidone—CYP2C8—Sorafenib—kidney cancer	0.0231	0.0461	CbGbCtD
Ketobemidone—CYP2C19—Sorafenib—kidney cancer	0.0194	0.0387	CbGbCtD
Ketobemidone—CYP2B6—Doxorubicin—kidney cancer	0.0185	0.037	CbGbCtD
Ketobemidone—CYP2C9—Paclitaxel—kidney cancer	0.0181	0.0362	CbGbCtD
Ketobemidone—CYP3A4—Pazopanib—kidney cancer	0.0161	0.0322	CbGbCtD
Ketobemidone—CYP2C9—Sorafenib—kidney cancer	0.0161	0.0322	CbGbCtD
Ketobemidone—CYP3A4—Erlotinib—kidney cancer	0.0115	0.023	CbGbCtD
Ketobemidone—CYP3A4—Paclitaxel—kidney cancer	0.0105	0.0211	CbGbCtD
Ketobemidone—CYP3A4—Sorafenib—kidney cancer	0.00936	0.0187	CbGbCtD
Ketobemidone—CYP3A4—Vinblastine—kidney cancer	0.00924	0.0185	CbGbCtD
Ketobemidone—CYP3A4—Vincristine—kidney cancer	0.00909	0.0182	CbGbCtD
Ketobemidone—CYP3A4—Sunitinib—kidney cancer	0.00759	0.0152	CbGbCtD
Ketobemidone—CYP3A4—Doxorubicin—kidney cancer	0.00568	0.0114	CbGbCtD
Ketobemidone—CYP2C19—urine—kidney cancer	0.00244	0.151	CbGeAlD
Ketobemidone—CYP2C9—urine—kidney cancer	0.00189	0.117	CbGeAlD
Ketobemidone—UGT1A9—renal system—kidney cancer	0.00161	0.0991	CbGeAlD
Ketobemidone—UGT1A9—kidney—kidney cancer	0.00156	0.0958	CbGeAlD
Ketobemidone—CYP3A4—urine—kidney cancer	0.00144	0.089	CbGeAlD
Ketobemidone—OPRD1—renal system—kidney cancer	0.00127	0.0784	CbGeAlD
Ketobemidone—OPRD1—kidney—kidney cancer	0.00123	0.0757	CbGeAlD
Ketobemidone—CYP2C8—renal system—kidney cancer	0.000522	0.0321	CbGeAlD
Ketobemidone—CYP2B6—nephron tubule—kidney cancer	0.000515	0.0317	CbGeAlD
Ketobemidone—CYP2C8—kidney—kidney cancer	0.000504	0.0311	CbGeAlD
Ketobemidone—CYP2B6—renal system—kidney cancer	0.000468	0.0288	CbGeAlD
Ketobemidone—CYP2B6—kidney—kidney cancer	0.000453	0.0279	CbGeAlD
Ketobemidone—PTGS1—renal system—kidney cancer	0.000423	0.0261	CbGeAlD
Ketobemidone—CYP2B6—gonad—kidney cancer	0.00042	0.0259	CbGeAlD
Ketobemidone—PTGS1—kidney—kidney cancer	0.000409	0.0252	CbGeAlD
Ketobemidone—PTGS1—cardiac atrium—kidney cancer	0.000379	0.0233	CbGeAlD
Ketobemidone—CYP3A4—renal system—kidney cancer	0.000353	0.0218	CbGeAlD
Ketobemidone—CYP3A4—kidney—kidney cancer	0.000342	0.021	CbGeAlD
Ketobemidone—CYP3A4—Metabolism—CCBL1—kidney cancer	1.44e-05	0.000344	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—SLC5A5—kidney cancer	1.43e-05	0.000344	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.43e-05	0.000343	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PGK1—kidney cancer	1.43e-05	0.000343	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—RAF1—kidney cancer	1.42e-05	0.00034	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—GSTP1—kidney cancer	1.42e-05	0.00034	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—POMC—kidney cancer	1.4e-05	0.000336	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—LDHB—kidney cancer	1.4e-05	0.000336	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—IL2—kidney cancer	1.4e-05	0.000336	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—ITPR2—kidney cancer	1.39e-05	0.000334	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—SLC2A1—kidney cancer	1.39e-05	0.000332	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PAK1—kidney cancer	1.38e-05	0.000331	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—JUNB—kidney cancer	1.38e-05	0.000331	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.34e-05	0.000322	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—ABCB1—kidney cancer	1.34e-05	0.000322	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IGF2—kidney cancer	1.33e-05	0.00032	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CA9—kidney cancer	1.33e-05	0.00032	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CDKN2B—kidney cancer	1.33e-05	0.000319	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.3e-05	0.000312	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—GSTM1—kidney cancer	1.3e-05	0.000312	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IGF1R—kidney cancer	1.29e-05	0.000309	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—POMC—kidney cancer	1.27e-05	0.000306	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—GSTT1—kidney cancer	1.27e-05	0.000305	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—ACHE—kidney cancer	1.27e-05	0.000305	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—IL2—kidney cancer	1.27e-05	0.000305	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CRABP1—kidney cancer	1.27e-05	0.000305	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PPAT—kidney cancer	1.24e-05	0.000298	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.24e-05	0.000298	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—RAF1—kidney cancer	1.24e-05	0.000298	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—CYP1A1—kidney cancer	1.23e-05	0.000296	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—IL2—kidney cancer	1.23e-05	0.000294	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CA9—kidney cancer	1.22e-05	0.000291	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—HIF1A—kidney cancer	1.21e-05	0.00029	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TSC2—kidney cancer	1.21e-05	0.00029	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—SCARB1—kidney cancer	1.2e-05	0.000289	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PTGS1—kidney cancer	1.19e-05	0.000286	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.19e-05	0.000285	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ITPR2—kidney cancer	1.18e-05	0.000283	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.17e-05	0.000281	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PSMD7—kidney cancer	1.17e-05	0.00028	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—KDR—kidney cancer	1.16e-05	0.000278	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—FH—kidney cancer	1.16e-05	0.000277	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—APRT—kidney cancer	1.16e-05	0.000277	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—GSTP1—kidney cancer	1.16e-05	0.000277	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CRABP1—kidney cancer	1.13e-05	0.000272	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IGF2—kidney cancer	1.13e-05	0.00027	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CDKN2B—kidney cancer	1.12e-05	0.000269	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—IL2—kidney cancer	1.11e-05	0.000267	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—BCHE—kidney cancer	1.11e-05	0.000266	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—SLC5A5—kidney cancer	1.09e-05	0.000262	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—ABCB1—kidney cancer	1.09e-05	0.000262	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IGF1R—kidney cancer	1.09e-05	0.000261	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.09e-05	0.000261	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GPC3—kidney cancer	1.09e-05	0.000261	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GSTT1—kidney cancer	1.08e-05	0.000258	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ACHE—kidney cancer	1.08e-05	0.000258	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—APC—kidney cancer	1.07e-05	0.000256	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—KIT—kidney cancer	1.07e-05	0.000256	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—HIF1A—kidney cancer	1.06e-05	0.000255	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—GSTM1—kidney cancer	1.06e-05	0.000255	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TSC2—kidney cancer	1.06e-05	0.000254	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CA2—kidney cancer	1.06e-05	0.000254	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—SLC2A1—kidney cancer	1.06e-05	0.000253	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ITPR2—kidney cancer	1.05e-05	0.000253	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—RAF1—kidney cancer	1.05e-05	0.000252	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—IL2—kidney cancer	1.04e-05	0.000249	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CRABP1—kidney cancer	1.03e-05	0.000248	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ALAD—kidney cancer	1.03e-05	0.000247	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—MAPK3—kidney cancer	1.02e-05	0.000245	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—SCARB1—kidney cancer	1.02e-05	0.000244	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—KDR—kidney cancer	1.02e-05	0.000244	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—POMC—kidney cancer	1.02e-05	0.000244	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.01e-05	0.000243	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PTGS1—kidney cancer	1.01e-05	0.000242	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CYP1A1—kidney cancer	1.01e-05	0.000241	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.01e-05	0.000241	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—BRAF—kidney cancer	1e-05	0.00024	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PSMD7—kidney cancer	9.9e-06	0.000237	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ALDH1A1—kidney cancer	9.84e-06	0.000236	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—MAPK1—kidney cancer	9.72e-06	0.000233	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.72e-06	0.000233	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GSTT1—kidney cancer	9.61e-06	0.00023	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ACHE—kidney cancer	9.61e-06	0.00023	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ITPR2—kidney cancer	9.61e-06	0.00023	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PGK1—kidney cancer	9.43e-06	0.000226	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SLC5A3—kidney cancer	9.43e-06	0.000226	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—IL2—kidney cancer	9.42e-06	0.000226	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—BCHE—kidney cancer	9.38e-06	0.000225	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—APC—kidney cancer	9.36e-06	0.000224	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—KIT—kidney cancer	9.36e-06	0.000224	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—PIK3CA—kidney cancer	9.29e-06	0.000223	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—SLC5A5—kidney cancer	9.27e-06	0.000222	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—LDHB—kidney cancer	9.25e-06	0.000222	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—POMC—kidney cancer	9.21e-06	0.000221	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—KRAS—kidney cancer	9.18e-06	0.00022	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—SCARB1—kidney cancer	9.1e-06	0.000218	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PTGS1—kidney cancer	9.01e-06	0.000216	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—HIF1A—kidney cancer	8.98e-06	0.000215	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—MAPK3—kidney cancer	8.96e-06	0.000215	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TSC2—kidney cancer	8.95e-06	0.000215	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—SLC2A1—kidney cancer	8.95e-06	0.000215	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—POMC—kidney cancer	8.91e-06	0.000214	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.86e-06	0.000212	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PSMD7—kidney cancer	8.83e-06	0.000212	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—GSTP1—kidney cancer	8.82e-06	0.000211	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—BRAF—kidney cancer	8.8e-06	0.000211	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GSTT1—kidney cancer	8.76e-06	0.00021	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ACHE—kidney cancer	8.76e-06	0.00021	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.68e-06	0.000208	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—KDR—kidney cancer	8.58e-06	0.000206	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—MAPK1—kidney cancer	8.53e-06	0.000204	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—PIK3CA—kidney cancer	8.44e-06	0.000202	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—RAF1—kidney cancer	8.38e-06	0.000201	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—BCHE—kidney cancer	8.37e-06	0.000201	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—ABCB1—kidney cancer	8.35e-06	0.0002	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—RELA—kidney cancer	8.34e-06	0.0002	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—SCARB1—kidney cancer	8.3e-06	0.000199	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—ERBB2—kidney cancer	8.29e-06	0.000199	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—SLC5A5—kidney cancer	8.27e-06	0.000198	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.27e-06	0.000198	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PTGS1—kidney cancer	8.21e-06	0.000197	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MTOR—kidney cancer	8.18e-06	0.000196	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—PIK3CA—kidney cancer	8.15e-06	0.000195	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—GSTM1—kidney cancer	8.1e-06	0.000194	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—KRAS—kidney cancer	8.05e-06	0.000193	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PSMD7—kidney cancer	8.05e-06	0.000193	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CA9—kidney cancer	8.02e-06	0.000192	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—SLC2A1—kidney cancer	7.99e-06	0.000192	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—KIT—kidney cancer	7.91e-06	0.00019	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—APC—kidney cancer	7.91e-06	0.00019	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.75e-06	0.000186	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CYP1A1—kidney cancer	7.68e-06	0.000184	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CDKN1B—kidney cancer	7.67e-06	0.000184	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—BCHE—kidney cancer	7.63e-06	0.000183	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—MAPK3—kidney cancer	7.57e-06	0.000182	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.57e-06	0.000182	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—SLC5A5—kidney cancer	7.54e-06	0.000181	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—POMC—kidney cancer	7.53e-06	0.00018	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—IL2—kidney cancer	7.51e-06	0.00018	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—POMC—kidney cancer	7.51e-06	0.00018	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GSTP1—kidney cancer	7.46e-06	0.000179	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—BRAF—kidney cancer	7.43e-06	0.000178	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—PIK3CA—kidney cancer	7.4e-06	0.000177	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—RAF1—kidney cancer	7.34e-06	0.000176	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PTGS2—kidney cancer	7.34e-06	0.000176	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CCND1—kidney cancer	7.32e-06	0.000176	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—RELA—kidney cancer	7.31e-06	0.000175	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—JUN—kidney cancer	7.31e-06	0.000175	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—SLC2A1—kidney cancer	7.28e-06	0.000175	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—ERBB2—kidney cancer	7.27e-06	0.000174	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CTNNB1—kidney cancer	7.25e-06	0.000174	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—MAPK1—kidney cancer	7.21e-06	0.000173	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MTOR—kidney cancer	7.17e-06	0.000172	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.07e-06	0.000169	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PTEN—kidney cancer	7.07e-06	0.000169	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ABCB1—kidney cancer	7.07e-06	0.000169	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—PIK3CA—kidney cancer	6.89e-06	0.000165	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GSTM1—kidney cancer	6.86e-06	0.000164	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CRABP1—kidney cancer	6.82e-06	0.000163	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—KRAS—kidney cancer	6.81e-06	0.000163	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.76e-06	0.000162	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CDKN1B—kidney cancer	6.73e-06	0.000161	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GSTP1—kidney cancer	6.66e-06	0.00016	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IL2—kidney cancer	6.58e-06	0.000158	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CYP1A1—kidney cancer	6.5e-06	0.000156	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CCND1—kidney cancer	6.42e-06	0.000154	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—JUN—kidney cancer	6.41e-06	0.000154	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PTEN—kidney cancer	6.4e-06	0.000154	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—VEGFA—kidney cancer	6.38e-06	0.000153	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CTNNB1—kidney cancer	6.36e-06	0.000152	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ITPR2—kidney cancer	6.34e-06	0.000152	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ABCB1—kidney cancer	6.31e-06	0.000151	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—PIK3CA—kidney cancer	6.25e-06	0.00015	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—RAF1—kidney cancer	6.21e-06	0.000149	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PTEN—kidney cancer	6.2e-06	0.000149	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—RELA—kidney cancer	6.18e-06	0.000148	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.16e-06	0.000148	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—ERBB2—kidney cancer	6.14e-06	0.000147	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GSTM1—kidney cancer	6.12e-06	0.000147	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GSTP1—kidney cancer	6.07e-06	0.000146	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MTOR—kidney cancer	6.06e-06	0.000145	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MAPK3—kidney cancer	6.04e-06	0.000145	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PTGS2—kidney cancer	5.99e-06	0.000144	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MYC—kidney cancer	5.87e-06	0.000141	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CYP1A1—kidney cancer	5.8e-06	0.000139	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GSTT1—kidney cancer	5.78e-06	0.000139	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ACHE—kidney cancer	5.78e-06	0.000139	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ABCB1—kidney cancer	5.75e-06	0.000138	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MAPK1—kidney cancer	5.74e-06	0.000138	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—POMC—kidney cancer	5.73e-06	0.000137	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CDKN1B—kidney cancer	5.69e-06	0.000136	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—VEGFA—kidney cancer	5.6e-06	0.000134	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GSTM1—kidney cancer	5.58e-06	0.000134	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IL2—kidney cancer	5.57e-06	0.000133	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SCARB1—kidney cancer	5.47e-06	0.000131	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—KRAS—kidney cancer	5.43e-06	0.00013	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CCND1—kidney cancer	5.43e-06	0.00013	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PTGS1—kidney cancer	5.42e-06	0.00013	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—JUN—kidney cancer	5.41e-06	0.00013	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CTNNB1—kidney cancer	5.37e-06	0.000129	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.34e-06	0.000128	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PSMD7—kidney cancer	5.31e-06	0.000127	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MAPK3—kidney cancer	5.29e-06	0.000127	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CYP1A1—kidney cancer	5.29e-06	0.000127	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PTEN—kidney cancer	5.24e-06	0.000126	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PTEN—kidney cancer	5.22e-06	0.000125	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MYC—kidney cancer	5.15e-06	0.000123	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MAPK1—kidney cancer	5.04e-06	0.000121	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—BCHE—kidney cancer	5.03e-06	0.000121	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PIK3CA—kidney cancer	4.98e-06	0.00012	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.97e-06	0.000119	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—POMC—kidney cancer	4.85e-06	0.000116	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TP53—kidney cancer	4.82e-06	0.000116	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SLC2A1—kidney cancer	4.8e-06	0.000115	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.77e-06	0.000114	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—KRAS—kidney cancer	4.76e-06	0.000114	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—VEGFA—kidney cancer	4.73e-06	0.000113	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PTGS2—kidney cancer	4.57e-06	0.00011	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PIK3CA—kidney cancer	4.52e-06	0.000108	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MAPK3—kidney cancer	4.47e-06	0.000107	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PIK3CA—kidney cancer	4.37e-06	0.000105	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MYC—kidney cancer	4.35e-06	0.000104	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.35e-06	0.000104	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—POMC—kidney cancer	4.33e-06	0.000104	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MAPK1—kidney cancer	4.26e-06	0.000102	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TP53—kidney cancer	4.23e-06	0.000101	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—KRAS—kidney cancer	4.02e-06	9.64e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GSTP1—kidney cancer	4.01e-06	9.6e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PTEN—kidney cancer	3.98e-06	9.55e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—POMC—kidney cancer	3.95e-06	9.46e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PTGS2—kidney cancer	3.87e-06	9.27e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ABCB1—kidney cancer	3.79e-06	9.09e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PIK3CA—kidney cancer	3.69e-06	8.86e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PIK3CA—kidney cancer	3.68e-06	8.83e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GSTM1—kidney cancer	3.68e-06	8.83e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TP53—kidney cancer	3.57e-06	8.57e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.49e-06	8.37e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PTGS2—kidney cancer	3.45e-06	8.27e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PTEN—kidney cancer	3.37e-06	8.08e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PTGS2—kidney cancer	3.15e-06	7.54e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PTEN—kidney cancer	3.01e-06	7.22e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PIK3CA—kidney cancer	2.81e-06	6.74e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PTEN—kidney cancer	2.74e-06	6.58e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—POMC—kidney cancer	2.6e-06	6.24e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PIK3CA—kidney cancer	2.38e-06	5.7e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PIK3CA—kidney cancer	2.12e-06	5.09e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PTGS2—kidney cancer	2.08e-06	4.98e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.94e-06	4.64e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PTEN—kidney cancer	1.81e-06	4.34e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.28e-06	3.06e-05	CbGpPWpGaD
